Carbiotix AB

Carbiotix AB

Share · SE0013016128 (XSTO)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Carbiotix AB
No Price
Share Float & Liquidity
Free Float 57,01 %
Shares Float 2,84 M
Shares Outstanding 4,98 M
Company Profile for Carbiotix AB Share
Carbiotix AB is a pre-clinical stage therapeutics company. It engages in the provision of products and medicines that produce good bacteria from intestine to counter metabolic and chronic diseases. The company was founded in 2014 and is headquartered in Lund, Sweden.

Company Data

Name Carbiotix AB
Company Carbiotix AB
Website http://www.carbiotix.com
Primary Exchange XSTO NASDAQ STOCKHOLM AB
ISIN SE0013016128
Asset Class Share
Sector Industrials
Industry Specialty Business Services
CEO Erik Deaner
Market Capitalization 33 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address ScheelevAegen 22, 223 63 Lund
IPO Date 2019-10-21

Stock Splits

Date Split
17.09.2024 1:100
12.05.2022 507:500

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB CRBX.ST
More Shares
Investors who hold Carbiotix AB also have the following shares in their portfolio:
Kansai Nerolac Paints Limited
Kansai Nerolac Paints Limited Share
Sturdy Industries Limited
Sturdy Industries Limited Share